(Sharecast News) - AstraZeneca said on Tuesday that a clinical trial studying its Imfinzi treatment showed positive results in patients with extensive-stage small-cell lung cancer (ES-SCLC).
The DeLLphi-305 Phase III trial found that a combination of Imfinzi with Amgen's Imdelltra delivered a statistically significant and highly clinically meaningful improvement in overall...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE